Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
Clinical trial NCT04255875 · COMPLETED
Trial details
- NCT number
- NCT04255875
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-05
- Primary completion
- 2023-07-07
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.